Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-20

Clinical Trial Update: Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Treating Patients With Fanconi Anemia [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating low-dose total-body irradiation and fludarabine phosphate followed by an unrelated donor stem cell transplant in patients with Fanconi …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fludarabine phosphate (Fludarabine phosphate)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Phase 1 | Status: COMPLETED